| Nov 6 |
Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall
|
| Nov 6 |
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
| Nov 6 |
Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
|
| Nov 6 |
Charles River Laboratories Non-GAAP EPS of $2.59 beats by $0.17, revenue of $1.01B beats by $34.5M
|
| Nov 6 |
Charles River: Q3 Earnings Snapshot
|
| Nov 6 |
Charles River Laboratories Announces Third-Quarter 2024 Results
|
| Nov 5 |
Charles River Laboratories Q3 2024 Earnings Preview
|
| Nov 4 |
Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics
|
| Nov 1 |
Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
|
| Oct 30 |
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
|
